DECOY THERAPEUTICS INC (DCOY) Stock Price & Overview
NASDAQ:DCOY • US79400X5032
The current stock price of DCOY is 0.6318 USD. Today DCOY is up by 8.46%. In the past month the price increased by 1.9%.
DCOY Key Statistics
- Market Cap
- 4.031M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -39.18
- Dividend Yield
- N/A
DCOY Stock Performance
DCOY Stock Chart
DCOY Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to DCOY.
DCOY Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to DCOY. While DCOY seems to be doing ok healthwise, there are quite some concerns on its profitability.
DCOY Earnings
DCOY Forecast & Estimates
DCOY Groups
Sector & Classification
DCOY Financial Highlights
Over the last trailing twelve months DCOY reported a non-GAAP Earnings per Share(EPS) of -39.18. The EPS increased by 68.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.08% | ||
| ROE | -117.81% | ||
| Debt/Equity | 0 |
DCOY Ownership
DCOY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.85 | 410.651B | ||
| AMGN | AMGEN INC | 16.4 | 197.945B | ||
| GILD | GILEAD SCIENCES INC | 16.14 | 180.072B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.4 | 116.919B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.36 | 80.868B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 47.87 | 42.343B | ||
| INSM | INSMED INC | N/A | 30.619B | ||
| NTRA | NATERA INC | N/A | 27.941B | ||
| BIIB | BIOGEN INC | 12.15 | 27.603B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.01 | 21.26B | ||
| MRNA | MODERNA INC | N/A | 21.03B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.746B | ||
| EXAS | EXACT SCIENCES CORP | 309.36 | 19.715B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DCOY
Company Profile
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2015-01-29. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.
Company Info
DECOY THERAPEUTICS INC
2450 Holcombe Blvd Ste J-608
Houston TEXAS US
Employees: 2
Phone: 13467720346
DECOY THERAPEUTICS INC / DCOY FAQ
What does DCOY do?
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2015-01-29. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.
Can you provide the latest stock price for DECOY THERAPEUTICS INC?
The current stock price of DCOY is 0.6318 USD. The price increased by 8.46% in the last trading session.
Does DECOY THERAPEUTICS INC pay dividends?
DCOY does not pay a dividend.
How is the ChartMill rating for DECOY THERAPEUTICS INC?
DCOY has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for DCOY stock?
DECOY THERAPEUTICS INC (DCOY) currently has 2 employees.
What is DECOY THERAPEUTICS INC worth?
DECOY THERAPEUTICS INC (DCOY) has a market capitalization of 4.03M USD. This makes DCOY a Nano Cap stock.
Can you provide the ownership details for DCOY stock?
You can find the ownership structure of DECOY THERAPEUTICS INC (DCOY) on the Ownership tab.